Chief.AI and Medicines Discovery Catapult have been awarded £370,000 of funding from Innovate UK to develop a searchable online platform that aims to make AI accessible to all drug discovery res
AstraZeneca has become the latest big pharma to jump on the artificial intelligence R&D bandwagon, penning a deal with the UK’s BenevolentAI to find new kidney and lung drugs.<
